Skip to main content

Table 1 Baseline characteristics of infants receiving early vs deferred ART

From: Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the C hildren with H IV E arly Antir etroviral Therapy (CHER) Study

Variable Early ART
(n = 75)
Deferred ART
(n = 38)
Total
(n = 113)
P-value
Female (%) 44 (59%) 23 (61%) 67 (59%) 1
Median age (weeks) 7.7 7.0 7.4 0.004
  (7.1 to 9.4) (6.5 to 8.5) (6.9 to 9.2)  
Median weight for age Z-score -0.55 -0.16 -0.47 0.08
  (-1.35 to 0.29) (-1.02 to 0.55) (-1.24 to 0.33)  
WHO Stage     
I 23 (31%) 14 (37%) 37 (33%) 0.67
II 14 (19%) 5 (13%) 19 (17%)  
III 38 (50%) 19 (50%) 57 (50%)  
Median CD4 % 35.2 35.8 35.6 0.89
  (28.4 to 40.6) (30.0 to 41.8) (28.9 to 40.6)  
Median CD4 count (cells/mm3) 1835 1728 1777 0.27
  (1362 to 2645) (1174 to 2195) (1325 to 2509)  
  1. Continuous data (IQR)
\